Serum and cellular interleukin-6 in haemodialysis patients: Relationship with energy expenditure

Nephrology Dialysis Transplantation

Volumn 22, Issue 3, 2007, Pages 839-844

  Kamimura, Maria A ^a   Draibe, Sergio A ^a   Dalboni, Maria A ^a   Cendoroglo, Miguel ^a   Avesani, Carla M ^a   Manfredi, Silvia R ^a   Canziani, Maria E F ^a   Cuppari, Lilian ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Energy expenditure; Haemodialysis; Inflammation; Interleukin 6; Monocytes

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGE; ARTICLE; BODY COMPOSITION; BODY MASS; CALORIMETRY; CELL LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENERGY EXPENDITURE; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IMPEDANCE; MAJOR CLINICAL STUDY; MALE; MONOCYTE; MULTIVARIATE ANALYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKINFOLD THICKNESS;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; ENERGY METABOLISM; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; RENAL DIALYSIS; TREATMENT OUTCOME;

EID: 33847624043     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl705     Document Type: Article

References (39)

1. Pecoits-Filho R, Bárany P, Lindholm B, Heimburger O, Stenvinkel P. Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 2002; 17: 1684-1688
2. Rao M, Guo D, Perianayagam MC et al. Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 2005; 45: 324-333
3. Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, consequences, and therapy. Semin Dial 2002; 15: 329-337
4. Memoli B, Libetta C, Rampino T et al. Hemodialysis related induction of interleukin-6 production by peripheral blood mononuclear cells. Kidney Int 1992; 42: 320-326
5. Girndt M, Sester U, Kaul H, Kohler H. Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell level. J Am Soc Nephrol 1998; 9: 1689-1996
6. Stenvinkel P, Barany P, Heimburger O, Pecoits-Filho R, Lindholm B. Mortality, malnutrition, and atherosclerosis in ESRD: What is the role of interleukin-6? Kidney Int Suppl 2002; 80: S103-S108
7. Kaizu Y, Kimura M, Yoneyama T, Mijaji K, Hibi I, Kumagai H. Interleukin-6 may mediate malnutrition in chronic hemodialysis patients. Am J Kidney Dis 1998; 31: 93-100
8. Kaizu Y, Ohkawa S, Odamaki M et al. Association between inflammatory mediators and muscle mass in long-term hemodialysis patients. Am J Kidney Dis 2003; 42: 295-302
9. Bistrain BS. Role of the systemic inflammatory response syndrome in the development of protein-calorie malnutrition in ESRD. Am J Kidney Dis 1998; 32: S113-S117
10. Kalantar-Zadeh K, Block G, McAllister CJ, Humphreys MH, Kopple JD. Appetite and inflammation, nutrition, anemia, and clinical outcome in hemodialysis patients. Am J Clin Nutr 2004; 80: 299-307
11. Falconer JS, Fearon KCH, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachetic patients with pancreatic cancer. Ann Surg 1994; 219: 325-331
12. Roubenoff R, Roubenoff RA, Cannon JG et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994; 93: 2379-2386
13. Garcia-Lorda P, Serrano P, Jiménez-Expósito J et al. Cytokine-driven inflammatory response is associated with the hypermetabolism of AIDS patients with opportunistic infections. J Parent Enteral Nutr 2000; 24: 317-322
14. Avesani CM, Draibe SA, Kamimura MA, Colugnati FA, Cuppari L. Resting energy expenditure of chronic kidney disease patients: Influence of renal function and subclinical inflammation. Am J Kidney Dis 2004; 44: 1008-1016
15. Utaka S, Avesani CM, Draibe S, Kamimura MA, Andreoni S, Cuppari L. Inflammation is associated with increased energy expenditure in chronic kidney disease patients. Am J Clin Nutr 2005; 82: 801-805
16. Wang AY, Sea MM, Tang N et al. Resting energy expenditure and subsequent mortality risk in peritoneal dialysis patients. J Am Soc Nephrol 2004; 15: 3134-3143
17. Weir JBV. New methods for calculating metabolic rate with special reference to protein metabolism. J Physiol Lond 1949; 109: 1-9
18. Kamimura MA, Avesani CM, Cendoroglo M, Canziani MEF, Draibe SA, Cuppari L. Comparison of skinfold thicknesses and bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body fat in patients on long-term hemodialysis therapy. Nephrol Dial Transplant 2003; 18: 101-105
19. Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: Measurements on 481 men and women aged 16 to 72 years. Br J Nutr 1974; 32: 77-97
20. Siri WE. Body composition from fluid spaces and density: Analysis of methods. In: J Brozek, A Henschel, eds. Techniques for Measuring Body Composition. National Research Council, Washington: 1961; 223-244
21. Detsky AS, McLaughlin JR, Baker JP et al. What is subjective global assessment of nutritional status? J Parenter Enteral Nutr 1987; 11: 8-13
22. National Kidney Foundation. K/DOQI - Kidney Disease Outcome Quality Initiative, Clinical practice guidelines. Am J Kidney Dis 2001; 37 [Suppl 2]: S27-S33
23. USRDS.Excerpts from United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis 1999; 34 [Suppl 1]: S1-S176
24. Monteon FJ, Laidlaw ST, Shaib JK, Kopple JD. Energy expenditure in patients with chronic renal failure. Kidney Int 1986; 30: 741-747
25. Schneeweiss B, Wolfgang G, Stockenhuber F et al. Energy metabolism in acute and chronic renal failure. Am J Clin Nutr 1990; 52: 596-601
26. Kamimura MA, Draibe SA, Avesani CM, Canziani MEF, Colugnati FAB, Cuppari L. Resting energy expenditure and its determinants in hemodialysis patients. Eur J Clin Nutr 2006 (in press)
27. Ikizler TA, Wingard RL, Sun M, Harvell J, Parker RA, Hakim RM. Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol 1996; 7: 2646-2656
28. Avesani CM, Draibe SA, Kamimura MA, Dalboni MA, Colugnati FA, Cuppari L. Decreased resting energy expenditure in non-dialyzed chronic kidney disease patients. Nephrol Dial Transplant 2004; 19: 3091-3097
29. O'Sullivan AJ, Lawson JA, Chan M, Kelly JJ. Body composition and energy metabolism in chronic renal insufficiency. Am J Kidney Dis 2002; 39: 369-375
30. Avesani CM, Cuppari L, Silva AC et al. Resting energy expenditure in pre-dialysis diabetic patients. Nephrol Dial Transplant 2001; 16: 556-560
31. Cuppari L, Carvalho AB, Avesani CM, Kamimura MA, Lobão RRS, Draibe SA. Increased resting energy expenditure in hemodialysis patients with severe secondary hiperparathyroidism. J Am Soc Nephrol 2004; 15: 2933-2939
32. Le Meur Y, Lorgeot V, Aldigier JC, Wijdenes J, Leroux-Robert C, Praloran V. Whole blood production of monocytic cytokines in haemodialysed patients. Nephrol Dial Transplant 1999; 14: 2420-2426
33. Malaponte G, Bevelacqua V, Fatuzzo P et al. IL-1β, TNF-α and IL-6 release from monocytes in haemodialysis patients in reation to dialytic age. Nephrol Dial Transplant 2002; 17: 1964-1970
34. Paczek L, Schaefer RM, Heidland A. Dialysis membranes decrease immunoglobulin and interleukin-6 production by peripheral blood mononuclear cells in vitro. Nephrol Dial Transplant 1991; 3: 41-44
35. Memoli B, Minutolo R, Bisesti V et al. Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes. Am J Kidney Dis 2002; 39: 266-273
36. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in hemodialysis. Kidney Int Suppl 2000; 58: S104-S111
37. Wisse BE. The inflammatory syndrome: The role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol 2004; 15: 2792-2800
38. Mohamed-Ali V, Goodrick S, Rawesh A et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200
39. Axelsson J, Qureshi AR, Suliman ME et al. Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 2004; 80: 1222-1229